Researchers must standardize medical histories if

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: ty of data in doubt with active-control trials but also the ‘‘quality’’ of research subjects. Researchers must standardize medical histories if they are to ensure their comparability—time-consuming, costly, and all but impossible tasks. Temple’s invalidation of the active-control trial is anthropologically and economically significant—the treat¨ ment naıve become preferable from a regulatory standpoint that emphasizes the importance of an efficient (and foolproof) global research subject. Precisely because they are often poor, without a treatment history, and without ¨ treatment, the treatment naıve are the more foolproof and valuable research subjects! 188...
View Full Document

This note was uploaded on 10/10/2010 for the course ENG 000121 taught by Professor Mcgrand during the Spring '10 term at Cornell University (Engineering School).

Ask a homework question - tutors are online